Additional European Equity News

Advanced Medical Solutions (AMS LN) - Inflexion is reportedly considering a takeover offer for the Co., via Sky News citing sources; sources downplayed any suggestion of live deal negotiations. (Sky News)

AstraZeneca (AZN LN) – Fasenra EGPA US FDA approval. (Newswires)

Davide Campari Milano (CPR IM) - CEO Matteo Fantacchiotti resigns; Paolo Marchesini appointed as interim co-ceo. (Newswires) 

Eutelsat (ETL FP) - Secures additional launches in new agreement with Mitsubishi Heavy Industries. (Newswires) 

Legal & General (LGEN LN) – Announced sale of Cala Group for an EV of GBP 1.35bln. Sale to result in GBP 1.16bln cash proceeds. (Newswires)

Novartis (NOVN SW) - New Novartis data in relapsing MS reinforce benefits of Kesmipta for first line and switch patients. Nearly 90% of first-line Kesimpta patients had no disability progression independent of relapse activity (PIRA) for up to six years in an analysis of open-label Alithios extension study. More than 80% of patients receiving first-line Kesimpta were progression-free for up to six years, reinforcing value of introducing Kesimpta early. Patients switching to Kesimpta from IV anti-CD20 therapy showed no new active lesions (GD+ T1) 12 months after switch in separate US single-arm, open-label, phase IIIB Olikos study. (Newswires) 

TotalEnergies (TTE FP) - Turkey has signed a 10-year LNG supply agreement with Co, with the option to redirect cargoes to Europe and Egypt. (Bloomberg)

URW (URW NA) - Pursues its deleverage progress with regional asset sales of EUR 0.5bln. (Newswires) 

Allianz (ALV GY) initiated with Buy at Goldman Sachs 

18 Sep 2024 - 07:45- EquitiesResearch Sheet- Source: Newsquawk